Brief: KalVista Pharmaceuticals Highlights Strategic Plans For Coming Fiscal Year

Kalvista Pharmaceuticals

01/05/2024 11:41

May 1 (Reuters) - Kalvista Pharmaceuticals Inc  KALV.O :
    * KALVISTA PHARMACEUTICALS HIGHLIGHTS STRATEGIC PLANS FOR
COMING
FISCAL YEAR
    * KALVISTA PHARMACEUTICALS INC: DEVELOPMENT STRATEGY REFINED
FOR
ORAL FACTOR XIIA PROGRAM
    * KALVISTA PHARMACEUTICALS: INTEND TO REDUCE SPENDING ON
DISCOVERY
& PRECLINICAL ACTIVITIES BY MORE THAN 75%, TO LESS THAN $5
MILLION PER YEAR
    * KALVISTA PHARMACEUTICALS INC: JNDA SUBMISSION TO JAPANESE
PHARMACEUTICALS AND MEDICAL DEVICES AGENCY PLANNED FOR Q4 2024
    * KALVISTA PHARMACEUTICALS INC: NEW DRUG APPLICATION
SUBMISSION TO
US FDA PLANNED FOR JUNE 2024

Source text for Eikon:  ID:nBw14yMh6a 
Further company coverage:  KALV.O